PhRMA Statement on FDA Authorizing Florida’s Importation Plan

WASHINGTON, D.C. (January 5, 2024) – Today, Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement in response to the U.S. Food and Drug Administration authorizing Florida’s Agency for Health Care Administration’s drug importation program: 

“We are deeply concerned with the FDA’s reckless decision to approve Florida’s state importation plan. Ensuring patients have access to needed medicines is critical, but the importation of unapproved medicines, whether from Canada or elsewhere in the world, poses a serious danger to public health. Politicians need to stop getting between Americans and their health care. PhRMA is considering all options for preventing this policy from harming patients.”